Bone metabolism in children with congenital hypothyroidism - A longitudinal study

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue 6, 1998, Pages 699-705

  Verrotti, Alberto ^a,d   Greco, Rita ^a   Altobelli, Emma ^b   Morgese, Guido ^c   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d Policlinico   (Italy)

Author keywords

Calcium metabolism; Congenital hypothyroidism; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; LEVOTHYROXINE; OSTEOCALCIN;

ARTICLE; BONE METABOLISM; CALCIUM METABOLISM; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; ECTOPIC HORMONE PRODUCTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; INFANT; MALE; NEWBORN; VITAMIN D METABOLISM;

EID: 0031755249     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1998.11.6.699     Document Type: Article

References (32)

1. Cooper DS. Thyroid hormone and the skeleton: a bone of contention. JAMA 1988; 259: 3175-3179.
2. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone metabolism and mineral metabolism. Endocrinol Metab Clin N Am 1990; 19: 35-51.
3. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 1987; 82: 1167-1170.
4. Auwerx J, Bouillon R. Mineral and bone metabolism in thyroid disease: a review. Q J Med 1986; 232: 737-752.
5. Jeune M, Muller JM. L'ostéopétrose myxoedèmateuse: hyperdensification généralisée du squelette au cours du myxoedème congénital. Pédiatrie 1959; 14: 43-50.
6. Job JC, Milhaud G, Antener I, Rossier A. Les anomalies du métabolisme calcique chez les enfants hypothyroidiens. Ann Pediatr 1967; 40: 648-653.
7. Mosekilde L, Lund B, Sørensen OH, Christensen MS, Meisen F. Serum 25-hydroxycholecalciferol in hyperthyroidism. Lancet 1977; I: 806-869.
8. Job JC, Ribiere M, Badoual J. Hypercalcemie, hypercalciurie et diminution du pouvoir concentrateur du rein au cours du traitement de l'hypothyroidie congénitale. Arch Fr Pèdiatr 1963; 2: 1033-1039.
9. Tau C, Garabedian M, D Ph, Farriaux JP, Czemichow P, Pomarede R, Balsan S. Hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin D and thyroid hormones. J Pediatr 1986; 109: 808-814.
10. Diamond T, Nery L, Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 1991; 72: 1184-1188.
11. Kooh SW, Brnjac L, Ehrlich RM, Qureshi R, Krishnan S. Bone mass in children with congenital hypothyroidism treated with thyroxine since birth. J Pediatr Endocrinol Metab 1996; 9: 59-62.
12. Ribot C, Tremollieres F, Pouilles JM, Louvet JP. Bone mineral density and thyroid hormone therapy. Clin Endocrinol 1990; 33: 143-153.
13. Weber G, Mora S, Bellini A, Bosco M, Prinster C, Siragusa V, di Natale B, Chiumello G. Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children. J Endocrinol Invest 1995; 18: 277-282.
14. Verrotti A, Blasetti A, Tumini S, Chiarelli F, Morgese G. Calcium homeostasis in prepubertal diabetic children. Acta Diabetol Lat 1988; 25: 173-177.
15. Bouillon R, Van Baelen H, De Moor P. The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab 1977; 45: 225-231.
16. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV, Lilley J, Heath DA, Sheppard MC. Long-term thyroxine treatment and bone mineral density. Lancet 1992; II: 9-13.
17. Fraser SA, Wilson GM. Plasma-calcitonin in disorders of thyroid function. Lancet 1971; I: 725-726.
18. Royer P, Mathieu H, Balsan S. Troubles du métabolisme calcique dans l'insuffisance thyroidienne de l'enfant. Ann Endocrinol 1968; 29: 610-621.
19. 3. J Clin Endocrinol Metab 1980; 51: 793-797.
20. Lekkerkerker JFF, Van Woundenberg F, Beekhuis H, Doorenbos H. Enhancement of calcium absorption in hypothyroidism. Isr J Med Sci 1971; 7: 399-401.
21. Hooft C, Vermassen A. Hypersensibilité à la vitamine D. Acta Paediatr Belg 1962; 16: 73-77.
22. Wilkins L. The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. 2nd Ed. Springfield, IL: Charles C Thomas, 1966; 488-489.
23. Body JJ, Heath H III. Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J Clin Endocrinol Metab 1983; 57: 897-903.
24. Oishi S, Shimada T, Tajiri J, Inoue J, Sato T. Elevated serum calcitonin levels in patients with thyroid disorders. Acta Endocrinol 1984; 107: 476-481.
25. Zamboni G, Avanzini S, Giavarina D, Tatò L. Monomeric calcitonin secretion in infants with congenital hypothyroidism. Acta Paediatr Scand 1989; 78: 885-888.
26. Bergmann P, Dediste A, Demeester-Mirkine N, Deconinck I, Corvilain J. Serum bone Gla protein (BGP) in primary hypothyroidism before and during treatment with thyroid hormones. Horm Metab Res 1989; 21: 47-48.
27. 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 1985; 76: 2254-2258.
28. Faber J, Perrild H, Johansen JS. Serum bone Gla protein (BGP) during treatment of hyperthyroidism and hypothyroidism. A longitudinal study. Horm Metab Res 1991; 23: 135-138.
29. Johansen JS, Hansen JM, Christiansen C. A radioimmunoassay for bone Gla protein (BGP) in human plasma. Acta Endocrinol (Copenh) 1987; 114: 410-416.
30. Coindre JM, David JP, Rivière L, Goussot JF, Roger P, de Mascarel A, Meunier PJ. Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med 1986; 146: 48-53.
31. Velentzan C, Orepoulos DG, From G, Porret B, Rapoport A. Vitamin-D levels in thyrotoxicosis. Lancet 1977; I: 370.
32. Laufer J, Noff D, Orda S, Sack J. Effect of short-term hyperthyroxinemia on vitamin D metabolism in congenital hypothyroidism. Horm Metab Res 1993; 25: 386-388.